8D43.2ICD-11 MMS 2026-01
Neuropathy due to toxicity
Description
In considering the diagnosis of toxic neuropathy, two criteria should be met: (1) Exposure can be verified and temporally related to the onset of clinical symptoms. Neuropathic symptoms usually occur concurrently with the exposure or following a variable latency of up to several months. (2) There must be neurological signs and abnormal electrodiagnostic studies, because many toxic neuropathies are subclinical, subjective symptoms may or may not occur. Removal from exposure results in cessation of progression of symptoms and the deficit. Most toxins produce symmetrical axonal degeneration in a length-dependent pattern, beginning in the distal segments of the long and large-calibre nerve fibres eventually spreading proximally with continued exposure. In addition to motor and/or sensory deficits, severe pain may be a characteristic feature.
Exclusions from above levels
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium19– Certain conditions originating in the perinatal period
Show allHide
22– Injury, poisoning or certain other consequences of external causes
Child codes
Foundation children elsewhere
8D44.0– Alcoholic polyneuropathy
Sibling codes
8D43.0– Encephalopathy due to toxicity8D43.1– Cognitive impairment due to toxicity8D43.3– Myopathy due to toxicity8D43.4– Movement disorders due to toxicity8D43.5– Cassava poisoning8D43.Y– Other specified neurological disorders due to toxicity8D43.Z– Neurological disorders due to toxicity, unspecified
Foundation entity
Neuropathy due to toxicity – http://id.who.int/icd/entity/1851919630
Allowed postcoordination axes
Part of: 8D43: Neurological disorders due to toxicity › 08: Diseases of the nervous system